Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

Item
http://www.wikidata.org/entity/Q48262352
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsStroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure RegistryAnticoagulation in Heart Failure: a Review.Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications.Anticoagulation Therapy and NOACs in Heart Failure.Stroke Risk and Mortality in Patients With Ventricular Assist Devices.The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores.CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.Heart Failure as a Risk Factor for Stroke.Updates on Prevention of Cardioembolic Strokes.
P2860

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

Item
http://www.wikidata.org/entity/Q48262352
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Risk of Stroke in Chronic Hear ...... za nell'Insufficienza Cardiaca
@en
Risk of Stroke in Chronic Hear ...... tinational Trial Heart Failure
@nl
type
label
Risk of Stroke in Chronic Hear ...... za nell'Insufficienza Cardiaca
@en
Risk of Stroke in Chronic Hear ...... tinational Trial Heart Failure
@nl
prefLabel
Risk of Stroke in Chronic Hear ...... za nell'Insufficienza Cardiaca
@en
Risk of Stroke in Chronic Hear ...... tinational Trial Heart Failure
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Risk of Stroke in Chronic Hear ...... za nell'Insufficienza Cardiaca
@en
P2093
P304
P31
P356
10.1161/CIRCULATIONAHA.114.013760
P407
P433
P478
P50
P577
P5875
P698
P921